Compare VTMX & BME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | VTMX | BME |
|---|---|---|
| Founded | 1998 | 2005 |
| Country | Mexico | United States |
| Employees | N/A | N/A |
| Industry | | Trusts Except Educational Religious and Charitable |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 536.7M |
| IPO Year | 2023 | N/A |
| Metric | VTMX | BME |
|---|---|---|
| Price | $31.12 | $41.27 |
| Analyst Decision | Hold | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $30.50 | N/A |
| AVG Volume (30 Days) | ★ 63.4K | 34.0K |
| Earning Date | 10-23-2025 | 01-01-0001 |
| Dividend Yield | 2.20% | ★ 6.26% |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.07 | ★ 1.44 |
| Revenue | ★ $271,805,969.00 | N/A |
| Revenue This Year | $12.90 | N/A |
| Revenue Next Year | $10.30 | N/A |
| P/E Ratio | $43.43 | ★ $28.37 |
| Revenue Growth | ★ 11.74 | N/A |
| 52 Week Low | $21.30 | $35.53 |
| 52 Week High | $32.21 | $43.20 |
| Indicator | VTMX | BME |
|---|---|---|
| Relative Strength Index (RSI) | 54.39 | 62.89 |
| Support Level | $30.21 | $40.41 |
| Resistance Level | $31.39 | $41.12 |
| Average True Range (ATR) | 0.81 | 0.41 |
| MACD | -0.11 | -0.03 |
| Stochastic Oscillator | 44.12 | 95.42 |
Corporacion Inmobiliaria Vesta SAB de CV is an internally managed real estate company that owns, manages, develops, and leases industrial properties in Mexico. The Company's primary business is the acquisition, development, and management of industrial and distribution center real estate. The company designs and constructs park-to-suit projects across various industries; undertakes build-to-suit projects; and provides site selection, design and engineering, and sale and leaseback services. The primary source of revenue is the rental income received from customers under operating leases. It serves aerospace, automotive, food and beverage, logistics, medical devices, plastics, and other industries.
Blackrock Health Sciences Trust has an investment objective to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Fund invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives.